From advancements in male birth control to the science of supplements, Scientific American highlights some of the most ...

When you take a drug, where in your body does it actually go? For most medications, scientists can make only educated guesses ...

Creating mini mitochondria factories helped recharge damaged cells in a dish, providing proof-of-concept work that could pave ...

Four autoimmune patients treated to date demonstrate deep B-cell depletion sustained for at least 28 days; initial efficacy ...

Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi ® (tafasitamab) in combination with rituximab and lenalidomide for adult ...

Scientists at Duke-NUS Medical School have developed two powerful computational tools that could transform how researchers ...

A small group of volunteers will receive multiple injections of the experimental treatments next month, says Unlimited Bio.

AstraZeneca said on Monday that a late‑stage trial testing its blockbuster therapy Imfinzi in combination with its experimental drug ceralasertib failed to improve the overall survival of patients ...

President Donald Trump announced Friday that nine additional pharmaceutical companies joined its most-favored-nation pricing ...

RIT launches comprehensive NSF workforce training program to equip graduate and doctoral students with broader experiences in ...

Issued on behalf of GT Biopharma, Inc.VANCOUVER, BC, Dec. 19, 2025 /PRNewswire/ -- USA News Group News Commentary – The recent FDA approval in November of the first bispecific antibody combination for ...

What began as a modular cleanroom provider has grown into an integrated organization supporting mission-critical environments ...